Media Summary: Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, remark on recommendations for Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, highlight Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, consider a role for

Initiating Therapy In Newly Diagnosed C Difficile - Detailed Analysis & Overview

Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, remark on recommendations for Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, highlight Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, consider a role for In this episode of Ask a Nurse, Cathy discusses a Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, review screening recommendations and ... Physicians with the Beacon Center for Infectious Diseases - specialists in diagnosing and treating infections - discuss a common ...

Dale N. Gerding, MD; Yoav Golan, MD; and Peter Salgo, MD, remark on recent updates to guidelines for the management of ... In this episode of Curbside Consults, we examine the latest guidelines on the management of Clostridiodes difficile ( Stuart Johnson, MD, infectious disease clinician in the Medicine/ID department at Loyola University Medical Center, discusses the ... Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, review further considerations for preventing ... Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, highlight common strategies for testing for ... Panelists Peter L. Salgo, MD; Dale N. Gerding, MD; Daniel E. Freedberg, MD, MS; Yoav Golan, MD, MS; Erik Dubberke, MD; and ...

JAMA. 2015;313(17):1719-1727. Read the article at: Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, discuss how the costs and benefits of newer ...

Photo Gallery

Initiating Therapy in Newly Diagnosed C. Difficile
Treatment Options for Newly Diagnosed C. Difficile
C. difficile, Diagnosis, Treatment, and Isolation
Empiric Therapy and C. Difficile Infection
C. diff Infection: Symptoms & Treatments - Ask A Nurse |  @LevelUpRN
Diagnosis and therapy of C.difficile infection -- with mild/moderate and severe disease
The Factors that Matter in C. Difficile Screening
Treating C-Difficile a Matter of Medication and Transplant Options
CASE DISCUSSION: Recurrent C. difficile in IBD:  How to manage, what to consider
“C. diff” - How It Spreads, Symptoms & Prevention
C difficile: A Change in First-Line Treatment and New Biologic Agent
Guideline Updates in the Management of C. Difficile
Sponsored
Sponsored
View Detailed Profile
Initiating Therapy in Newly Diagnosed C. Difficile

Initiating Therapy in Newly Diagnosed C. Difficile

Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, remark on recommendations for

Treatment Options for Newly Diagnosed C. Difficile

Treatment Options for Newly Diagnosed C. Difficile

Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, highlight

Sponsored
C. difficile, Diagnosis, Treatment, and Isolation

C. difficile, Diagnosis, Treatment, and Isolation

MDstewardship Educational Series.

Empiric Therapy and C. Difficile Infection

Empiric Therapy and C. Difficile Infection

Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, consider a role for

C. diff Infection: Symptoms & Treatments - Ask A Nurse |  @LevelUpRN

C. diff Infection: Symptoms & Treatments - Ask A Nurse | @LevelUpRN

In this episode of Ask a Nurse, Cathy discusses a

Sponsored
Diagnosis and therapy of C.difficile infection -- with mild/moderate and severe disease

Diagnosis and therapy of C.difficile infection -- with mild/moderate and severe disease

Antimicrobial Resistance Case Study 6.

The Factors that Matter in C. Difficile Screening

The Factors that Matter in C. Difficile Screening

Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, review screening recommendations and ...

Treating C-Difficile a Matter of Medication and Transplant Options

Treating C-Difficile a Matter of Medication and Transplant Options

C

CASE DISCUSSION: Recurrent C. difficile in IBD:  How to manage, what to consider

CASE DISCUSSION: Recurrent C. difficile in IBD: How to manage, what to consider

New

“C. diff” - How It Spreads, Symptoms & Prevention

“C. diff” - How It Spreads, Symptoms & Prevention

Physicians with the Beacon Center for Infectious Diseases - specialists in diagnosing and treating infections - discuss a common ...

C difficile: A Change in First-Line Treatment and New Biologic Agent

C difficile: A Change in First-Line Treatment and New Biologic Agent

New

Guideline Updates in the Management of C. Difficile

Guideline Updates in the Management of C. Difficile

Dale N. Gerding, MD; Yoav Golan, MD; and Peter Salgo, MD, remark on recent updates to guidelines for the management of ...

Diagnosis and Treatment of C. difficile Infection with Dr. Jessica Allegretti

Diagnosis and Treatment of C. difficile Infection with Dr. Jessica Allegretti

In this episode of Curbside Consults, we examine the latest guidelines on the management of Clostridiodes difficile (

Treating C. difficile: The Downside to Current Approaches

Treating C. difficile: The Downside to Current Approaches

Stuart Johnson, MD, infectious disease clinician in the Medicine/ID department at Loyola University Medical Center, discusses the ...

Additional Insight on Managing C. Difficile Infection

Additional Insight on Managing C. Difficile Infection

Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, review further considerations for preventing ...

Strategies for Detecting C. Difficile Infection

Strategies for Detecting C. Difficile Infection

Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, highlight common strategies for testing for ...

Clostridium Difficile Infection: Old Treatments and New Strategies - Linda Cheung, PharmD

Clostridium Difficile Infection: Old Treatments and New Strategies - Linda Cheung, PharmD

Linda Cheung, PharmD, speaks about the

Current Understanding of the Dominant Strains of Clostridium Difficile

Current Understanding of the Dominant Strains of Clostridium Difficile

Panelists Peter L. Salgo, MD; Dale N. Gerding, MD; Daniel E. Freedberg, MD, MS; Yoav Golan, MD, MS; Erik Dubberke, MD; and ...

Nontoxigenic Clostridium difficile for Prevention of Recurrent Infection

Nontoxigenic Clostridium difficile for Prevention of Recurrent Infection

JAMA. 2015;313(17):1719-1727. Read the article at: http://ja.ma/1IrNG2q.

Cost-Benefit Analysis for C. Difficile Infection Therapies

Cost-Benefit Analysis for C. Difficile Infection Therapies

Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, discuss how the costs and benefits of newer ...